1 - 10 out of 27Page size: 10
  1. 2022

  2. Trends and regional variations of gonococcal antimicrobial resistance in the Netherlands, 2013 to 2019

    Visser, M., Götz, H. M., van Dam, A. P. & van Benthem, B. H., 25 Aug 2022, In: Euro surveillance. 27, 34, p. 1-13 13 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  3. The impact of the COVID-19 pandemic on hepatitis B virus vaccination and transmission among men who have sex with men: A mathematical modelling study

    Xiridou, M., Adam, P., Meiberg, A., Visser, M., Matser, A., de Wit, J. & op de Coul, E., 5 Aug 2022, In: Vaccine. 40, 33, p. 4889-4896 8 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  4. Europe-wide expansion and eradication of multidrug-resistant Neisseria gonorrhoeae lineages: a genomic surveillance study

    Centre for Genomic Pathogen Surveillance and the Euro-GASP study group, 1 Jun 2022, In: The Lancet. Microbe. 3, 6, p. e452-e463

    Research output: Contribution to journal › Article › Academic › peer-review

  5. 2021

  6. Associations between antimicrobial susceptibility/resistance of Neisseria gonorrhoeae isolates in European Union/European Economic Area and patients’ gender, sexual orientation and anatomical site of infection, 2009–2016

    on behalf of The Euro-GASP Network, 1 Dec 2021, In: BMC infectious diseases. 21, 1, 273.

    Research output: Contribution to journal › Article › Academic › peer-review

  7. Two European Examples of Acute Geriatric Units Located Outside of a General Hospital for Older Adults With Exacerbated Chronic Conditions

    Ribbink, M. E., Gual, N., MacNeil-Vroomen, J. L., Ars Ricart, J., Buurman, B. M., Inzitari, M., AGCH-Study Group, Franssen, R., Frenkel, W. J., Henstra, M. J., van Maanen, M. A., Oudejans, I., Parlevliet, J. L., van Poelgeest, E. P., Resodikromo, M. N., Kaland, K. J., van der Velde, N., Visser, M. E. & Willems, H. C., Jun 2021, In: Journal of the American Medical Directors Association. 22, 6, p. 1228-1234 7 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  8. Ending risk-group HBV vaccination for MSM after the introduction of universal infant HBV vaccination: A mathematical modelling study

    Xiridou, M., Visser, M., Urbanus, A., Matser, A., van Benthem, B. & Veldhuijzen, I., 18 May 2021, In: Vaccine. 39, 21, p. 2867-2875

    Research output: Contribution to journal › Article › Academic › peer-review

  9. 2020

  10. Impact of frequent testing on the transmission of HIV and N. gonorrhoeae among men who have sex with men: a mathematical modelling study

    Reitsema, M., Heijne, J., Visser, M., van Sighem, A., Schim van der Loeff, M., op de Coul, E. L. M., Bezemer, D., Wallinga, J., van Benthem, B. H. B. & Xiridou, M., 1 Aug 2020, In: Sexually transmitted infections. 96, 5, p. 361-367 7 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  11. 2019

  12. Hepatitis B and C screening needs among different ethnic groups: A population-based study in Amsterdam, the Netherlands

    Zuure, F., Bil, J., Visser, M., Snijder, M., Boyd, A., Blom, P., Sonder, G., Schinkel, J. & Prins, M., 1 Aug 2019, In: JHEP Reports. 1, 2, p. 71-80 10 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  13. Cost-effectiveness of increased HIV testing among MSM in the Netherlands

    Reitsema, M., Steffers, L., Visser, M., Heijne, J., van Hoek, A. J., Schim van der Loeff, M., van Sighem, A., van Benthem, B., Wallinga, J., Xiridou, M. & Mangen, M-J., 2019, In: AIDS (London, England). 33, 12, p. 1807-1817

    Research output: Contribution to journal › Article › Academic › peer-review

  14. 2012

  15. Antisense oligonucleotides for the treatment of dyslipidaemia

    Visser, M. E., Witztum, J. L., Stroes, E. S. G. & Kastelein, J. J. P., 2012, In: European heart journal. 33, 12, p. 1451-1458

    Research output: Contribution to journal › Review article › Academic › peer-review

Previous 1 2 3 Next

ID: 103186